Effects of circulating member B of the family with sequence similarity 3 on the risk of developing metabolic syndrome and its components: A 5‐year prospective study

Member B of the family with sequence similarity 3 (FAM3B), also known as pancreatic‐derived factor, is mainly synthesized and secreted by islet β‐cells, and plays a role in abnormal metabolism of glucose and lipids. However, the prospective association of FAM3B with metabolic disorders remains unclear. The present study aimed to reveal the predictive relationship between pancreas‐specific cytokine and metabolic syndrome (MetS).

[1]  W. Teng,et al.  Comparison of anthropometric indices for predicting the risk of metabolic syndrome and its components in Chinese adults: a prospective, longitudinal study , 2017, BMJ Open.

[2]  J. Segura-Egea,et al.  Role of leptin as a link between metabolism and the immune system. , 2017, Cytokine & growth factor reviews.

[3]  H. El-Mesallamy,et al.  Association of serum pancreatic derived factor (PANDER) with beta-cell dysfunction in type 2 diabetes mellitus. , 2017, Journal of diabetes and its complications.

[4]  J. Mechanick,et al.  The Adipokine-Cardiovascular-Lifestyle Network: Translation to Clinical Practice. , 2016, Journal of the American College of Cardiology.

[5]  Hong Wang,et al.  The Effects of Serum ANGPTL8/betatrophin on the Risk of Developing the Metabolic Syndrome – A Prospective Study , 2016, Scientific Reports.

[6]  Yanbing Li,et al.  Elevated circulating level of a cytokine, pancreatic‐derived factor, is associated with metabolic syndrome components in a Chinese population , 2015, Journal of diabetes investigation.

[7]  B. Burkhardt,et al.  Hepatic nutrient and hormonal regulation of the PANcreatic-DERived factor (PANDER) promoter , 2015, Molecular and Cellular Endocrinology.

[8]  LeeKayoung,et al.  Adiponectin Levels and Longitudinal Changes in Metabolic Syndrome: The Healthy Twin Study. , 2015 .

[9]  R. Wong,et al.  Prevalence of the metabolic syndrome in the United States, 2003-2012. , 2015, JAMA.

[10]  Jaspinder Kaur.  A Comprehensive Review on Metabolic Syndrome , 2014, Cardiology research and practice.

[11]  Mary T. Brinkoetter,et al.  Circulating irisin in relation to insulin resistance and the metabolic syndrome. , 2013, The Journal of clinical endocrinology and metabolism.

[12]  B. Burkhardt,et al.  PANcreatic‐DERived factor: Novel hormone PANDERing to glucose regulation , 2011, FEBS letters.

[13]  Jichun Yang,et al.  Pancreatic‐derived factor promotes lipogenesis in the mouse liver: Role of the Forkhead box 1 signaling pathway , 2011, Hepatology.

[14]  S. Grundy,et al.  Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International As , 2009, Circulation.

[15]  K. Xiang,et al.  Optimal waist circumference cutoffs for abdominal obesity in Chinese. , 2008, Atherosclerosis.

[16]  B. Wolf,et al.  Over-expression of CLN3P, the Batten disease protein, inhibits PANDER-induced apoptosis in neuroblastoma cells: further evidence that CLN3P has anti-apoptotic properties. , 2006, Molecular genetics and metabolism.

[17]  B. Wolf,et al.  PANDER-induced cell-death genetic networks in islets reveal central role for caspase-3 and cyclin-dependent kinase inhibitor 1A (p21). , 2006, Gene.

[18]  B. Wolf,et al.  Mechanisms of glucose-induced secretion of pancreatic-derived factor (PANDER or FAM3B) in pancreatic beta-cells. , 2005, Diabetes.

[19]  B. Wolf,et al.  Structure−Function Studies of PANDER, an Islet Specific Cytokine Inducing Cell Death of Insulin-Secreting β Cells† , 2005 .

[20]  B. Wolf,et al.  Effects of overexpression of pancreatic derived factor (FAM3B) in isolated mouse islets and insulin-secreting betaTC3 cells. , 2005, American journal of physiology. Endocrinology and metabolism.

[21]  B. Wolf,et al.  Pancreatic-derived factor (FAM3B), a novel islet cytokine, induces apoptosis of insulin-secreting beta-cells. , 2003, Diabetes.

[22]  G. Lewis,et al.  Mechanisms of HDL lowering in insulin resistant, hypertriglyceridemic states: the combined effect of HDL triglyceride enrichment and elevated hepatic lipase activity. , 2003, Clinical biochemistry.

[23]  Michael A. Briggs,et al.  Cloning, expression, and initial characterization of a novel cytokine-like gene family. , 2002, Genomics.

[24]  Yun-Mi Song,et al.  Adiponectin Levels and Longitudinal Changes in Metabolic Syndrome: The Healthy Twin Study. , 2015, Metabolic syndrome and related disorders.

[25]  H. Minuk,et al.  Metabolic syndrome. , 2005, Journal of insurance medicine.